Loading... Please wait...

EagleBio's Total Testosterone ELISA Used in a Recent Study

Posted by

Eagle Bioscience’s Total Testosterone ELISA Assay Kit was used in a recent study. This kit is part of our line of Steroid Assay Kits which is a line of highly sensitive and specific assays used to detect a variety of samples in serum, plasma, tissue, urine, and saliva.

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

Background

Prostate cancer patients on androgen deprivation therapy (ADT) experience adverse effects such as lean mass loss, known as sarcopenia, fat gain, and changes in cardiometabolic factors that increase risk of metabolic syndrome (MetS). Resistance training can increase lean mass, reduce body fat, and improve physical function and quality of life, but no exercise interventions in prostate cancer patients on ADT have concomitantly improved body composition and MetS. This pilot trial investigated 12 weeks of resistance training on body composition and MetS changes in prostate cancer patients on ADT. An exploratory aim examined if a combined approach of training and protein supplementation would elicit greater changes in body composition.

Conclusions

A 12-week resistance training intervention effectively improved sarcopenia, body fat %, strength and quality of life in hypogonadal prostate cancer patients, but did not change MetS or physical function. PRO did not offer additional benefit in improving body composition.

Dawson, Jacqueline K., et al. “Impact of Resistance Training on Body Composition and Metabolic Syndrome Variables during Androgen Deprivation Therapy for Prostate Cancer: a Pilot Randomized Controlled Trial.” BMC Cancer, vol. 18, no. 1, 3 Apr. 2018, p. 368., doi:10.1186/s12885-018-4306-9.



Eagle Biosciences, Inc.
20A NW Blvd., Suite 112
Nashua, NH 03063
Email: info@eaglebio.com
Toll Free: 866-411-8023
International: +617-419-2019